Daxor Announces Christiana Care Health System Acquires Second Blood Volume Analyzer BVA-100 at Wilmington Hospital
NEW YORK, NY--(Marketwire - July 9, 2007) - Daxor Corporation (AMEX: DXR), a medical
instrumentation and biotechnology company, today announced the receipt of a
signed trial agreement from Christiana Care Health System for its second
Blood Volume Analyzer BVA-100 to be located at Wilmington Hospital, in the
downtown business district of Wilmington, Delaware. Christiana Care's
first BVA-100 was installed and purchased at Christiana Hospital, located
on a suburban campus south of the City of Wilmington.
Christiana Care Health System, which dates back to 1888, is one of the
region's largest not-for profit health care providers, serving the people
of Delaware as well as neighboring Maryland, Pennsylvania and New Jersey.
It is recognized as a regional center for excellence in cardiology, cancer
and women's health services, as well as Level-I trauma care and Level-3
neonatal intensive care (both highest intensity). Christiana Care operates
two hospitals, Christiana Hospital and Wilmington Hospital.
Christiana Care offers nearly 1,100 licensed hospital beds in two
hospitals, a major regional Center for Heart and Vascular Health and the
only Level-I trauma service on the East Coast corridor between Philadelphia
and Baltimore.
Dr. Timothy Manzone, Associate Medical Director of Nuclear Medicine of
Christiana Care Health System, noted that, "Since December 2004, when we
installed our first blood volume analyzer at Christiana Hospital, we
have seen increasing clinical interest in BVA studies. The availability of
rapid, accurate volume status assessment is proving of significant value in
management of heart failure, as well as in critical care, perioperative
management, and hematology. Other potential applications for blood volume
analysis are continuing to emerge. Clinicians in our system have become
accustomed to ordering blood volume analysis when they need this
information for patient management, and we realized it was important that
we make BVA studies readily available at both hospitals in our system."
Daxor Corporation manufactures and markets the BVA-100, a semi-automated
Blood Volume Analyzer. The BVA-100 is used in conjunction with Volumex,
Daxor's single use diagnostic kit. For more information regarding Daxor
Corporation's Blood Volume Analyzer BVA-100, visit Daxor's website
www.Daxor.com.
Contact Information: Contact Information:
Stephen Feldschuh
Chief Operating Officer
212-330-8515
or
Diane Meegan
Investor Relations
212-330-8512